MRM Health: €55 Million Series B Raised For Microbiome-Based Drug Candidates
By Amit Chowdhry ● Sep 12, 2025
MRM Health has completed a €55 million Series B financing round that will enable the company to push its microbiome-based drug candidates through critical development milestones and broaden its pipeline of live biotherapeutic products. Biocodex, a French pharmaceutical group with a decades-long focus on microbiota science, led the round. It included participation from ATHOS, BNP Paribas Fortis Private Equity, and existing backers such as SFPIM, Ackermans & van Haaren, OMX Europe Venture Fund, Qbic II, and VIB.